2016
DOI: 10.1016/j.phytochem.2016.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxic cardenolides and sesquiterpenoids from the fruits of Reevesia formosana

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 39 publications
0
7
0
2
Order By: Relevance
“…The known compounds lincomolide A ( 3 ) [ 24 ], linderanolide B ( 4 ) [ 25 ], isolinderanolide B ( 5 ) [ 25 ], isophilippinolide A ( 6 ) [ 26 ], secosubamolide ( 7 ) [ 27 ], reticuol ( 8 ) [ 28 ], burmanol ( 9 ) [ 29 ], (−)-5,7-dimethoxy-3′,4′-methylenedioxy-flavan-3-ol ( 10 ) [ 30 ], taxifolin ( 11 ) [ 31 ], (−)-yangambin ( 12 ) [ 32 ], (−)-pinoresinol ( 13 ) [ 33 ], (+)-monomethylpinoresinol ( 14 ) [ 34 ], (+)-syringaresinol ( 15 ) [ 33 ], erythro -guaiacylglycerol- β - O -4′-(5′)-methoxylariciresinol ( 16 ) [ 35 ], caryolane-1,9 β -diol ( 17 ) [ 36 ], β -sitosterol ( 18 ) [ 37 ], and cinnamtannin B1 ( 19 ) [ 38 ] were identified by comparisons of physical and spectroscopic data ([α] D , UV, IR, 1 H NMR, and MS) with authentic samples or literature data. Among them, cinnamtannin B1 ( 19 ) (3.6 g) was obtained as the major constituent.…”
Section: Resultsmentioning
confidence: 99%
“…The known compounds lincomolide A ( 3 ) [ 24 ], linderanolide B ( 4 ) [ 25 ], isolinderanolide B ( 5 ) [ 25 ], isophilippinolide A ( 6 ) [ 26 ], secosubamolide ( 7 ) [ 27 ], reticuol ( 8 ) [ 28 ], burmanol ( 9 ) [ 29 ], (−)-5,7-dimethoxy-3′,4′-methylenedioxy-flavan-3-ol ( 10 ) [ 30 ], taxifolin ( 11 ) [ 31 ], (−)-yangambin ( 12 ) [ 32 ], (−)-pinoresinol ( 13 ) [ 33 ], (+)-monomethylpinoresinol ( 14 ) [ 34 ], (+)-syringaresinol ( 15 ) [ 33 ], erythro -guaiacylglycerol- β - O -4′-(5′)-methoxylariciresinol ( 16 ) [ 35 ], caryolane-1,9 β -diol ( 17 ) [ 36 ], β -sitosterol ( 18 ) [ 37 ], and cinnamtannin B1 ( 19 ) [ 38 ] were identified by comparisons of physical and spectroscopic data ([α] D , UV, IR, 1 H NMR, and MS) with authentic samples or literature data. Among them, cinnamtannin B1 ( 19 ) (3.6 g) was obtained as the major constituent.…”
Section: Resultsmentioning
confidence: 99%
“…1 Reevesiterpenol E also displayed the best selective cytotoxicity to the NCI-H460 cell line. 2 Therefore, the cardenolides and furanosesquiterpenoids from R. formosana are hopeful to be candidates for the discovery of anticancer compounds, primarily, the anticancer mechanisms had been studied by our research group. Such as reevesioside A induced G1 arrest and suppressed the expression of c-myc of human hormone-refractory prostate cancer, 3 and the anti-proliferative activity of reevesioside F was conrmed to be Na + /K + -ATPase a3 subunitdependent 4 whereas the function of epi-reevesioside F was further identied to be PI3-kinase/Akt pathway related.…”
Section: Resultsmentioning
confidence: 99%
“…Continuing these rigorous studies, three cardenolides: reevesioside J, reevesioside K, and epi-reevesioside K, three sesquiterpenoids: reevesiterpenols C-E, and two glycosides: reevesianins A and B, along with 46 known compounds were also isolated from the fruits of R. formosana. 2 Among these isolates, all cardenolides showed signicant cytotoxicity against MCF-7, NCI-H460, and HepG2 cancer cell lines and reevesiterpenol E also exhibited the best selective cytotoxicity to the NCI-H460 cell line. Furthermore, reevesioside A, 3 reevesioside F, 4 and epi-reevesioside F 5 had already been discussed for the mechanism of several cancer cells.…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation
“…Прогнозування та оцінка терапевтичного ефекту обраної схеми лікування на основі фармакокінетичних параметрів ґрунтується на математичному моделюванні, яке засноване на концентрації лікарського засобу у крові, визначення якої називають терапевтичним лікарським моніторингом (ТЛМ). Кінетичний підхід до моніторингу лікування ґрунтується на припущенні, що величина терапевтичного та токсичного ефектів залежить від дози, а також від концентрації діючої речовини у крові [5,6,11]. Однак, антибіотики різних груп за рахунок особливостей хімічної структури, мають різні властивості.…”
unclassified